Until invited to report on the Ocular Therapeutics Conference (OTC), I’d thought the acronym stood for ‘over the counter’. I wondered if I was being sent to report on the OTT advertising of a certain pharmacy chain. However, the OTC is the only New Zealand meeting focused entirely on ocular therapeu
The pinnacle event for everyone in eyewear design, technology, materials and more, the 32nd edition of the Silmo d’Or Awards once again spotlighted the industry’s abundant excellence, innovation, craftsmanship and creativity.
The 30th annual meeting of the Australasian Society of Cataract and Refractive Surgeons (AUSCRS) was held in Darwin for four days. The theme for this year’s meeting was ‘Disconnect to Reconnect’. It was a vibrant mix of scientific presentations, spirited discussions and debates, all while maintainin
Dr Hannah Kersten shares some of the the highlights and pearls from this year's NOSA meeting in Auckland
Dr Moaz Alshaikhi reviews three retinal studies including one on a new sustained-release anti-VEGF treatment
Link: https://www.nzoptics.co.nz/live-articles/save-sight-symposium-2024-ideas-and-innovations-in-eye-health/
https://nzoptics.co.nz/live-articles/ccls-2025-talking-collaboration/
https://www.nzoptics.co.nz/live-articles/covid-associated-with-amn-spike/
Throughout the retail calendar, I’ve noticed that window displays are changed frequently to align with various events. In fact, if you take a closer look, you'll find that each month has its own celeb
Central serous chorioretinopathy (CSCR) is a commonly encountered chorioretinal disorder affecting working-age adults, the majority of whom (especially in acute presentations) achieve spontaneous resolution of subretinal fluid and visual improvement within three to six months1.
Central serous chorioretinopathy (CSCR), characterised by serous detachment of the neurosensory retina and detachments of an altered retinal pigment epithelium (RPE), can be frustrating for both patie
In choosing from the expanding list of options for glaucoma surgery, we should be seeking to optimise efficacy, safety and consider costs. An ideal glaucoma operation immediately results in: a stable
